Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

400
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
400
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

3.6K
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
3.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

1.2K
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
1.2K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

679
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
679
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

595
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
595
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

2.7K
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing HPV Vaccination Rates in the Primary Care Setting.

Journal of doctoral nursing practice·2023
Same author

Reduced sphingolipid biosynthesis modulates proteostasis networks to enhance longevity.

Aging·2023
Same author

Transection injury differentially alters the proteome of the human sural nerve.

PloS one·2022
Same author

Monosomy X in Female Mice Influences the Regional Formation and Augments the Severity of Angiotensin II-Induced Aortopathies.

Arteriosclerosis, thrombosis, and vascular biology·2020
Same author

RNA Sequencing of Human Peripheral Nerve in Response to Injury: Distinctive Analysis of the Nerve Repair Pathways.

Cell transplantation·2020
Same author

"You Can't Be What You Can't See"-Are Women in Pediatric Urology Visible at National Meetings?

Urology·2020

Related Experiment Video

Updated: Mar 29, 2026

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.9K

The Challenges of Interstitial Cystitis: Current Status and Future Prospects.

Samuel Belknap1, Eric Blalock2, Deborah Erickson3

  • 1Department of Urology, University of Kentucky College of Medicine, 800 Rose St., MS-269, Lexington, KY, 40536-0298, USA. sbe242@uky.edu.

Drugs
|November 26, 2015
PubMed
Summary

Interstitial cystitis/bladder pain syndrome (IC/BPS) is challenging to treat due to unknown causes. Biomarkers are needed to match patients with the correct therapy and improve outcomes.

More Related Videos

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.5K
Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

17.6K

Related Experiment Videos

Last Updated: Mar 29, 2026

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.9K
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.5K
Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

17.6K

Area of Science:

  • Urology
  • Pain Management
  • Biomarker Discovery

Background:

  • Interstitial cystitis/bladder pain syndrome (IC/BPS) presents with bladder pain and urinary symptoms.
  • Current treatments target proposed etiologies like urothelial dysfunction, inflammation, or neuropathic pain.
  • Effective treatment is hindered by the inability to distinguish between off-target therapies and sub-therapeutic interventions.

Purpose of the Study:

  • To highlight the critical need for biomarkers in IC/BPS treatment.
  • To propose a future direction for personalized medicine in IC/BPS.

Main Methods:

  • Review of current understanding of IC/BPS etiologies and treatment strategies.
  • Analysis of the challenges in differentiating treatment failures.
  • Conceptual proposal for biomarker-guided therapy selection and monitoring.

Main Results:

  • IC/BPS has multiple proposed etiologies, complicating treatment selection.
  • Treatment failure can result from targeting the wrong cause or using insufficient therapy.
  • The lack of specific biomarkers prevents precise patient stratification and treatment monitoring.

Conclusions:

  • Identifying specific urine or serum biomarkers for each IC/BPS etiology is crucial.
  • Biomarkers would enable patient selection for targeted treatments.
  • Biomarkers would allow monitoring of treatment efficacy on the intended biological target, advancing IC/BPS management.